Crossmark

An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding

Crossref DOI link: https://doi.org/10.1186/s13020-022-00635-2

Published Online: 2022-07-27

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yip, Ka Man

Lee, Kwan Ming

Ng, Tzi Bun

Xu, Shujun

Yung, Ken Kin Lam

Qu, Shaogang

Cheung, Allen Ka Loon

Sze, Stephen Cho Wing https://orcid.org/0000-0002-4561-1214
Funding

Funding for this research was provided by:

Hong Kong Baptist University (RC-SGT2/18-19/SCI/002)

University Grants Committee (RMGS2020_5_02, RMGS2020_3_05)
License Information

Text and Data Mining valid from 2022-07-27

Version of Record valid from 2022-07-27
More Information

Article History

Received: 18 January 2022

Accepted: 18 June 2022

First Online: 27 July 2022

Declarations

:

: Not applicable.

: All authors agree to publish our findings.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below